PIK3R4

Chr 3

phosphoinositide-3-kinase regulatory subunit 4

Also known as: VPS15, p150

Predicted to enable protein serine/threonine kinase activity. Involved in several processes, including autophagosome maturation; early endosome to late endosome transport; and phosphatidylinositol 3-kinase/protein kinase B signal transduction. Located in late endosome. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
11
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
0.39
LOEUF
—
Mechanism

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.39LOEUF
pLI 0.025
Z-score 5.43
OE 0.26 (0.17–0.39)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
2.48Z-score
OE missense 0.74 (0.69–0.80)
548 obs / 737.4 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.26 (0.17–0.39)
0≤0.351.4
Missense OE?0.74 (0.69–0.80)
0≤0.61.4
Synonymous OE?0.99
0≤1.21.6
LoF obs/exp: 16 / 62.3Missense obs/exp: 548 / 737.4Syn Z: 0.17

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

PIK3R4 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →